Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Ising

Showing results (41-50 of 148) with videos related to

Pageof 15
Sort By:
Depression and Anxiety|February 11, 2003
Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depressionTom Bschor, Christopher Baethge, Mazda Adli, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 8, 2013
Prediction of antidepressant treatment response from gray matter volume across diagnostic categoriesPhilipp G Sämann, David Höhn, Natalya Chechko, et al.
CNS Spectrums|July 25, 2013
The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot studyBarbara Breitenstein, Sandra Scheuer, Hildegard Pfister, et al.
Journal of Psychiatric Research|December 14, 2004
Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depressionHeike E Künzel, Marcus Ising, Astrid W Zobel, et al.
Biological Psychology|September 30, 2014
Increased HPA axis response to psychosocial stress in remitted depression: the influence of coping styleNina Höhne, Maximilian Poidinger, Franziska Merz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 18, 2009
HTR2A gene variation is involved in antidepressant treatment responseSusanne Lucae, Marcus Ising, Sonja Horstmann, et al.
Journal of Psychiatric Research|October 18, 2003
Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effectsHeike E Künzel, Astrid W Zobel, Thomas Nickel, et al.
The International Journal of Neuropsychopharmacology|December 19, 2014
FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controlsNina Höhne, Maximilian Poidinger, Franziska Merz, et al.
Neuropsychobiology|August 18, 2009
Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activityMazda Adli, Tom Bschor, Michael Bauer, et al.
Clinical Epigenetics|April 28, 2022
Effects of stressful life-events on DNA methylation in panic disorder and major depressive disorderDarina Czamara, Alexa Neufang, Roman Dieterle, et al.
Pageof 15

Showing results (41-50 of 148) with videos related to

Sort By:
Pageof 15
Depression and Anxiety|February 11, 2003
Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depressionTom Bschor, Christopher Baethge, Mazda Adli, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 8, 2013
Prediction of antidepressant treatment response from gray matter volume across diagnostic categoriesPhilipp G Sämann, David Höhn, Natalya Chechko, et al.
CNS Spectrums|July 25, 2013
The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot studyBarbara Breitenstein, Sandra Scheuer, Hildegard Pfister, et al.
Journal of Psychiatric Research|December 14, 2004
Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depressionHeike E Künzel, Marcus Ising, Astrid W Zobel, et al.
Biological Psychology|September 30, 2014
Increased HPA axis response to psychosocial stress in remitted depression: the influence of coping styleNina Höhne, Maximilian Poidinger, Franziska Merz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 18, 2009
HTR2A gene variation is involved in antidepressant treatment responseSusanne Lucae, Marcus Ising, Sonja Horstmann, et al.
Journal of Psychiatric Research|October 18, 2003
Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effectsHeike E Künzel, Astrid W Zobel, Thomas Nickel, et al.
The International Journal of Neuropsychopharmacology|December 19, 2014
FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controlsNina Höhne, Maximilian Poidinger, Franziska Merz, et al.
Neuropsychobiology|August 18, 2009
Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activityMazda Adli, Tom Bschor, Michael Bauer, et al.
Clinical Epigenetics|April 28, 2022
Effects of stressful life-events on DNA methylation in panic disorder and major depressive disorderDarina Czamara, Alexa Neufang, Roman Dieterle, et al.
Pageof 15